查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1873991

生物活性傷口管理市場

Bioactive Wound Management Market
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5個工作天內

價格
簡介目錄

2024年，生物活性傷口管理市場規模約為25.2億美元，預計到2031年將達到42.8億美元，在此期間的複合年成長率（CAGR）為8.3%。生物活性傷口管理市場的一個顯著趨勢是將3D列印技術應用於傷口護理管理。

生物活性傷口管理市場分析

生物活性傷口管理市場的成長主要受慢性損傷盛行率上升和手術數量增加的推動。由於手術頻率的增加，預計全球手術部位感染率將上升。而手術頻率的上升主要歸因於各種慢性疾病發生率的增加。根據美國國立衛生研究院 (NIH) 統計，歐洲每年約進行 2,000 萬例大型手術。在杜拜，杜拜衛生局 (DHA) 報告稱，2021 年杜拜共進行了約 15.9 萬例手術，其中美容手術數量從 2020 年的 223,507 例加倍，達到 2022 年的 583,909 例。生物活性傷口管理產品有助於加速手術部位感染的癒合，預計手術數量的成長將在不久的將來推動對這些產品的需求。

生物活性傷口管理市場概覽

北美目前佔據生物活性傷口管理市場最大的佔有率，這主要歸功於該地區對創新產品研發的大量投資以及眾多領先製藥公司的佈局。北美公司受惠於其全球分銷網路，能夠觸及世界各地的不同市場。亞太地區預計將成為成長最快的地區，其中印度、中國和澳洲等國家將引領這一成長，這主要得益於慢性傷口盛行率的上升、糖尿病和老齡化人口的成長以及醫療設施的改善。此外，該地區活躍的傷口護理管理機構也帶來了豐厚的成長機會。

戰略洞察

生物活性傷口管理市場的促進因素與機會

傷口護理產品技術的進步將惠及市場

為了滿足日益成長的需求，創新且經濟高效的傷口癒合技術正在不斷研發。傷口管理的發展歷程已從基礎敷料過渡到旨在維持濕潤癒合環境的先進傷口護理產品。角蛋白基傷口護理產品通常與這些先進敷料搭配使用，以促進傷口上皮再生。這些產品能夠被傷口吸收，進而減少換藥次數，促進傷口癒合。此外，使用生物支架材料，包括完整的細胞外基質（ECM）或其成分，為改善傷口微環境、加速皮膚修復提供了新的治療選擇。

傷口護理產品領域的主要進展：

• Integra Life Sciences 提供多種傷口管理解決方案，包括 Integra 雙層傷口基質、Integra 網狀雙層傷口基質和 Integra 流動性傷口基質。這些產品由交聯牛膠原蛋白、糖胺聚醣和矽酮製成，用於治療部分和全層傷口、壓瘡、靜脈潰瘍、糖尿病潰瘍、慢性血管潰瘍和手術傷口。

Matristem（ACell公司）採用天然細胞外基質支架，該支架由非交聯的豬膀胱基底膜細胞外基質（UBM-ECM）組成。 UBM-ECM 的一個關鍵優勢在於它保留了膀胱基底膜成分，該成分可將上皮組織錨定到皮膚和血管等器官的細胞外基質上。

新型傷口治療方法的研究計畫不斷增加—這是一個機會

慢性傷口給外科醫生帶來挑戰，常常導致併發症。隨著慢性傷口患者數量的增加，迫切需要系統性的治療方法，從而推動了循證護理的普及。研究和臨床試驗表明，生物活性傷口護理產品可以促進濕性傷口的癒合。政府機構和研究機構正積極推動傷口護理領域的進步，一些組織致力於開發創新傷口護理產品，這為預測期內的成長創造了機會。

近期發展實例：

  • 2023年7月，貝爾法斯特女王大學的研究人員開發了一種治療糖尿病足潰瘍（DFU）的新方法，該方法使用一種稱為支架的3D列印繃帶。這項創新技術結合了脂質奈米顆粒和水凝膠，製造出個人化的類皮膚支架，可釋放大量且持續劑量的載藥分子，用於治療DFU，有望徹底改變糖尿病潰瘍的治療方式。
  • 2023年6月，伯明翰大學的研究人員推出了一項新技術，證明將銀摻入「生物活性玻璃」中可以更長時間地保持其抗菌性能。與傳統方法相比，這種組合能提供更有效、更持久的抗菌傷口保護。生物活性玻璃是一種獨特的合成生物材料，由矽膠製成，先前曾用於骨移植。

生物活性傷口管理市場區隔分析

生物活性傷口管理市場分析的關鍵細分市場包括產品類型、應用和最終用戶。

  • 按產品分類，市場分為生物工程皮膚替代品、膠原蛋白敷料、抗菌敷料、藻酸鹽和水膠體，其中藻酸鹽部分在 2023 年佔據最大的市場佔有率。
  • 按應用領域分類，市場分為壓瘡、糖尿病足潰瘍、靜脈腿部潰瘍、燒傷傷口和手術傷口，其中燒傷傷口領域在 2023 年佔據市場佔有率領先地位。
  • 從最終用戶來看，市場分為醫院和診所、門診手術中心和其他，其中醫院和診所將在 2023 年佔據市場主導地位。

生物活性傷口管理市場的地理分析

生物活性傷口管理市場報告依地域分類為五大區域：北美、亞太、歐洲、中東和非洲以及南美/中南美洲。北美一直是生物活性傷口管理市場的領先區域。由於多種因素，包括眾多醫療器材製造商生產生物活性傷口管理產品，以及政府在提供先進工具和技術以實現最佳傷口護理方面的支持，預計美國市場將成為規模最大、成長最快的市場。美國企業正透過內生式和外延式策略拓展業務。例如，2021年10月，美敦力公司宣布投資7,750萬美元在堪薩斯州建立新的配送中心。因此，美國對傷口敷料日益成長的需求為主要企業在傷口照護管理領域進行創新提供了重要機會。預計亞太地區未來幾年將實現最高的複合年成長率。

生物活性傷口管理市場報告範圍

生物活性傷口管理市場的最新發展

生物活性傷口管理市場評估是基於從一手和二手研究中收集的定性和定量資料，包括主要企業出版物、協會資料和資料庫。生物活性傷口管理市場的最新發展包括：

  • 2022年7月，史密斯醫療推出了WOUND COMPASS臨床支援應用程式，這是一款針對醫療保健專業人員的綜合性數位化工具，旨在協助進行傷口評估和決策，以減少實踐差異。 （資料來源：史密斯醫療，2022）
  • 2022年6月，美敦力公司推出了Optifoam Gentle EX泡棉敷料，該敷料旨在用於壓力性損傷預防方案時減輕壓力，其獨特的五層結構可吸收剪切力和摩擦力，同時還能有效吸濕。 （資料來源：美敦力，2022）
  • 2022年1月，康維特收購了Triad Life Sciences Inc.，此舉鞏固了康維特在美國高級傷口護理領域的地位，並確保了其獲得能夠改善高級傷口管理和患者預後的互補創新技術。 （圖片來源：康維特，2022）
  • 2021年2月，AxioBiosolutions的MaxioCel系列新一代先進傷口護理產品獲得歐洲CE認證，使Axio得以進入全球快速成長的價值140億美元的先進傷口護理市場。 （資料來源：AxioBiosolutions，2021）

生物活性傷口管理市場報告的覆蓋範圍和交付成果

這份題為《生物活性傷口管理市場規模及預測（2021-2031）》的報告對市場進行了全面分析，涵蓋以下領域：

  • 涵蓋範圍內所有關鍵細分市場的全球、區域和國家層面的市場規模和預測
  • 市場動態，例如促進因素、限制因素和關鍵機會
  • 未來主要趨勢
  • 詳細的PEST/波特五力模型與SWOT分析
  • 全球及區域市場分析，涵蓋關鍵趨勢、主要參與者、法規及最新發展
  • 產業格局和競爭分析，包括市場集中度、熱力圖分析、主要參與者和最新發展動態
  • 公司詳細概況
  • 史密斯和內普

目錄

第1章：引言

第2章：生物活性傷口管理市場及主要結論

第3章：研究方法

  • 覆蓋範圍
  • 二手研究
  • 初步研究

第4章：生物活性傷口管理市場概況

  • 概述
  • PEST分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲和中美洲
  • 專家意見

第5章：全球生物活性傷口管理市場及產業動態

  • 市場促進因素
    • 傷口和潰瘍發生率不斷上升
    • 全球外科手術數量不斷成長
    • 先進傷口護理產品的創新
  • 市場限制
    • 傷口護理管理的高昂成本
  • 市場機遇
    • 加強研究力度，推出新型傷口治療方法
  • 未來趨勢
    • 3D列印在傷口護理管理的應用
  • 影響分析

第6章：生物活性傷口管理市場及全球分析

  • 全球生物活性傷口管理市場收入預測與分析
  • 全球生物活性傷口管理市場（依地域分類）－預測與分析
  • 關鍵參與者的市場定位

第7章：生物活性傷口管理市場及產品分類

  • 概述
  • 2024 年及 2031 年生物活性傷口管理市場佔有率（依產品分類）
  • 海藻酸鹽
    • 概述
    • 海藻酸鹽：生物活性傷口管理市場、市場規模、收入及至2031年的預測
  • 膠原蛋白敷料
    • 概述
    • 膠原蛋白敷料：生物活性傷口管理市場、市場規模及收入預測（至2031年）
  • 抗菌敷料
    • 概述
    • 抗菌敷料：生物活性傷口管理市場、市場規模、收入及至2031年的預測
  • 生物工程皮膚替代品
    • 概述
    • 生物工程皮膚替代品：生物活性傷口管理市場、市場規模、收入及至2031年的預測
  • 水膠體
    • 概述
    • 水膠體：生物活性傷口管理市場、市場規模、收入及至2031年的預測

第8章：生物活性傷口管理市場分析與應用

  • 概述
  • 2024 年和 2031 年生物活性傷口管理市場佔有率（按應用領域分類）
  • 壓瘡
  • 糖尿病足潰瘍
  • 靜脈性腿部潰瘍
  • 燒傷傷口
  • 手術傷口

第9章：生物活性傷口管理市場分析及最終用戶細分

  • 概述
  • 2024 年和 2031 年生物活性傷口管理市場佔有率（按最終用戶分類）
  • 醫院和診所
  • 門診手術中心
  • 其他

第10章：生物活性傷口管理市場及地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
  • 南美洲和中美洲
    • 巴西
    • 阿根廷

第11章：新冠疫情對全球生物活性傷口管理市場的影響

  • 北美洲
  • 歐洲
  • 亞太
  • 世界其他地區

第12章：生物活性傷口管理市場及產業概況

  • 概述
  • 市場中各公司採取的成長策略（%）
  • 有機發展
    • 概述
  • 無機物發展
    • 概述

第13章：公司簡介

  • Covalon Technologies Ltd.
  • ConvaTec Group Plc
  • Coloplast Group
  • Tissue Regenix Group
  • Hartman Group
  • Smith and Nephew
  • Integra Life Sciences Corporation
  • Organogenesis Inc.
  • MiMedx
  • ETS Wound Care, LLC

第14章：附錄

簡介目錄
Product Code: TIPMD00002256

The Bioactive Wound Management Market was valued at approximately US$ 2.52 billion in 2024 and is projected to reach US$ 4.28 billion by 2031, reflecting a CAGR of 8.3% during this period. A significant trend in the Bioactive Wound Management Market is the integration of 3D Printing in Wound Care Management.

Analysis of the Bioactive Wound Management Market

The growth of the bioactive wound management market is driven by the increasing prevalence of chronic injuries and a higher number of surgical procedures. The global rise in surgical site infections is anticipated due to the growing frequency of surgeries. This increase is largely attributed to the rising incidence of various chronic diseases. According to the National Institutes of Health (NIH), around 20 million major surgeries are performed annually in Europe. In Dubai, the Dubai Health Authority (DHA) reported approximately 159,000 surgeries in 2021, with the number of cosmetic surgeries doubling from 223,507 in 2020 to 583,909 in 2022. Bioactive wound management products facilitate quicker healing of surgical site infections, and the growing number of surgical procedures is expected to drive demand for these products in the near future.

Overview of the Bioactive Wound Management Market

North America currently holds the largest share of the bioactive wound management market, attributed to significant investments in the development of innovative products and the presence of leading pharmaceutical companies in the region. North American companies benefit from a global distribution network that allows them to reach various markets worldwide. The Asia Pacific region is anticipated to be the fastest-growing area, with countries like India, China, and Australia leading this growth due to the increasing prevalence of chronic wounds, a rising diabetic and aging population, and enhancements in healthcare facilities. Additionally, the presence of active wound care management organizations in the region presents lucrative growth opportunities.

Strategic Insights

Drivers and Opportunities in the Bioactive Wound Management Market

Advancements in Wound Care Products to Benefit the Market

Innovative and cost-effective wound-healing technologies are being developed to address the growing demand. The evolution of wound management has transitioned from basic dressings to advanced wound care products designed to maintain a moist healing environment. Keratin-based wound care products are often used alongside these advanced dressings to promote wound re-epithelialization. These products enhance healing by being absorbed into the wounds, reducing the frequency of dressing changes. Moreover, the use of biological scaffold materials, including intact extracellular matrix (ECM) or its components, offers new therapeutic options that focus on the wound microenvironment and expedite skin restoration.

Notable Advancements in Wound Care Products:

• Integra Life Sciences provides a variety of wound management solutions, including the Integra Bilayer Wound Matrix, Integra Meshed Bilayer Wound Matrix, and Integra Flowable Wound Matrix. These products, made from cross-linked bovine collagen, glycosaminoglycan, and silicone, are utilized for managing partial and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, and surgical wounds.

• Matristem (ACell Inc.) features a natural ECM scaffold composed of non-cross-linked porcine UBM-ECM. A key advantage of UBM-ECM is its retention of the urinary bladder's basement membrane component, which anchors epithelial tissues to the ECM in organs like skin and blood vessels.

Growing Research Initiatives for Novel Wound Treatments - An Opportunity

Chronic wounds pose challenges for surgeons, often leading to complications. As the number of patients with chronic wounds increases, there is a pressing need for systematic treatment approaches, driving the adoption of evidence-based care. Research and clinical trials indicate that bioactive wound care products can enhance the healing of moist wounds. Government agencies and research institutions are actively promoting advancements in wound care, with several organizations dedicated to developing innovative wound care products, creating growth opportunities in the forecast period.

Examples of Recent Developments:

  • In July 2023, researchers from Queen's University Belfast developed a novel treatment for diabetic foot ulcers (DFUs) using a 3D-printed bandage known as a scaffold. This innovative technology combines lipid nanoparticles and hydrogels to create personalized skin-like scaffolds that release both bulk and sustained doses of antibiotic-loaded molecules for DFU treatment, potentially revolutionizing diabetic ulcer care.
  • In June 2023, researchers from the University of Birmingham introduced a technique demonstrating that silver retains its antimicrobial properties longer when incorporated into 'bioactive glass'. This combination offers more effective and durable antimicrobial wound protection compared to traditional alternatives. Bioactive glasses are a unique class of synthetic biomaterials made from silicone, previously used in bone grafting.

Segmentation Analysis of the Bioactive Wound Management Market

Key segments contributing to the bioactive wound management market analysis include product type, application, and end user.

  • By product, the market is categorized into bioengineered skin substitutes, collagen-based dressings, antimicrobial dressings, alginates, and hydrocolloids, with the alginates segment holding the largest market share in 2023.
  • By application, the market is divided into pressure ulcers, diabetic foot ulcers, venous leg ulcers, burn wounds, and surgical wounds, with the burn wounds segment leading the market share in 2023.
  • In terms of end users, the market is segmented into hospitals & clinics, ambulatory surgical centers, and others, with hospitals & clinics dominating the market in 2023.

Geographical Analysis of the Bioactive Wound Management Market

The bioactive wound management market report is segmented geographically into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America. North America has been the leading region in the bioactive wound management market. The US market is expected to be the largest and fastest-growing due to several factors, including the presence of numerous medical device manufacturers producing bioactive wound management products and government support in providing advanced tools and technologies for optimal wound care. Companies in the US are expanding their presence through both organic and inorganic strategies. For example, in October 2021, Medline Industries announced a US$ 77.5 million investment to establish a new distribution center in Kansas. Thus, the growing demand for wound dressings in the US presents significant opportunities for key players to innovate in wound care management. The Asia Pacific region is projected to experience the highest CAGR in the coming years.

Scope of the Bioactive Wound Management Market Report

Recent Developments in the Bioactive Wound Management Market

The bioactive wound management market is assessed through qualitative and quantitative data collected from primary and secondary research, including key corporate publications, association data, and databases. Recent developments in the bioactive wound management market include:

  • In July 2022, Smith+Nephew launched the WOUND COMPASS Clinical Support App, a comprehensive digital tool for healthcare professionals aimed at assisting in wound assessment and decision-making to reduce practice variation. (Source: Smith+Nephew, 2022)
  • In June 2022, Medline introduced the Optifoam Gentle EX Foam Dressing, designed to alleviate pressure when used in pressure injury prevention protocols, featuring five unique layers to absorb shear force and friction while managing moisture. (Source: Medline, 2022)
  • In January 2022, Convatec acquired Triad Life Sciences Inc., enhancing Convatec's position in Advanced Wound Care in the US and securing access to complementary innovative technology that improves advanced wound management and patient outcomes. (Source: Convatec, 2022)
  • In February 2021, AxioBiosolutions received CE certification in Europe for its MaxioCel line of next-generation advanced wound care products, allowing Axio to enter the rapidly growing USD 14 billion advanced wound care market globally. (Source: AxioBiosolutions, 2021)

Coverage and Deliverables of the Bioactive Wound Management Market Report

The report titled "Bioactive Wound Management Market Size and Forecast (2021-2031)" provides a comprehensive analysis of the market, covering the following areas:

  • Market size and forecast at global, regional, and country levels for all key market segments included in the scope
  • Market dynamics such as drivers, restraints, and key opportunities
  • Key future trends
  • Detailed PEST/Porter's Five Forces and SWOT analysis
  • Global and regional market analysis covering key trends, major players, regulations, and recent developments
  • Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments
  • Detailed company profiles
  • Smith+Nephew

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Bioactive Wound Management Marketand By Product
    • 1.3.2 Global Bioactive Wound Management Marketand By Application
    • 1.3.3 Global Bioactive Wound Management Marketand By End User
    • 1.3.4 Global Bioactive Wound Management Marketand By Geography

2. Bioactive Wound Management Marketand Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Bioactive Wound Management Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America
    • 4.2.2 Europe
    • 4.2.3 APAC
    • 4.2.4 Middle East and Africa
    • 4.2.5 South and Central America
  • 4.3 Expert Opinion

5. Global Bioactive Wound Management Marketand Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of Wounds and Ulcers
    • 5.1.2 Growing Number of Surgical Procedures Worldwide
    • 5.1.3 Innovation in Advanced Wound Care Products
  • 5.2 Market Restraints
    • 5.2.1 High Cost Associated with Wound Care Management
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Research Activities to Introduce Novel Wound Treatments
  • 5.4 Future Trends
    • 5.4.1 3D Printing in Wound Care Management
  • 5.5 Impact analysis

6. Bioactive Wound Management Marketand Global Analysis

  • 6.1 Global Bioactive Wound Management Market Revenue Forecast and Analysis
  • 6.2 Global Bioactive Wound Management Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Bioactive Wound Management Marketand By Product

  • 7.1 Overview
  • 7.2 Bioactive Wound Management Market Share, by Product, 2024 and 2031 (%)
  • 7.3 Alginates
    • 7.3.1 Overview
    • 7.3.2 Alginates: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.4 Collagen-based Dressing
    • 7.4.1 Overview
    • 7.4.2 Collagen-based Dressing: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.5 Antimicrobial Dressings
    • 7.5.1 Overview
    • 7.5.2 Antimicrobial Dressings: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.6 Bioengineered Skin Substitutes
    • 7.6.1 Overview
    • 7.6.2 Bioengineered Skin Substitutes: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)
  • 7.7 Hydrocolloids
    • 7.7.1 Overview
    • 7.7.2 Hydrocolloids: Bioactive Wound Management Market Marketand Revenue and Forecast to 2031 (US$ million)

8. Bioactive Wound Management Market Analysis and By Application

  • 8.1 Overview
  • 8.2 Bioactive Wound Management Market Share, by Application, 2024 and 2031 (%)
  • 8.3 Pressure Ulcers
    • 8.3.1 Overview
    • 8.3.2 Pressure Ulcers: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Diabetic Foot Ulcers
    • 8.4.1 Overview
    • 8.4.2 Diabetic Foot Ulcers: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Venous Leg Ulcers
    • 8.5.1 Overview
    • 8.5.2 Venous Leg Ulcers: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Burn Wounds
    • 8.6.1 Overview
    • 8.6.2 Burn Wounds: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 8.7 Surgical Wounds
    • 8.7.1 Overview
    • 8.7.2 Surgical Wounds: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)

9. Bioactive Wound Management Market Analysis and By End User

  • 9.1 Overview
  • 9.2 Bioactive Wound Management Market Share, by End User, 2024 and 2031 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (US$ Million)

10. Bioactive Wound Management Market and Geographic Analysis

  • 10.1 North America: Bioactive Wound Management Market
    • 10.1.1 Overview
    • 10.1.2 North America: Bioactive Wound Management Market - Revenue and Forecast to 2031 (USD Million)
    • 10.1.3 North America Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.1.4 North America Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 10.1.5 North America Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.6 North America: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.1.7 US: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.7.1 US: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.1 US Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.2 US Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.1.7.1.3 US Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.8 Canada: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.8.1 Canada: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.1 Canada Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.2 Canada Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.1.8.1.3 Canada Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.1.9 Mexico: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.1.9.1 Mexico: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.1 Mexico Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.2 Mexico Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.1.9.1.3 Mexico Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.2 Europe: Bioactive Wound Management Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Bioactive Wound Management Market - Revenue and Forecast to 2031 (USD Million)
    • 10.2.3 Europe Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.2.4 Europe Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 10.2.5 Europe Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.6 Europe: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.2.7 Germany: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.7.1 Germany: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.1 Germany Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.2 Germany Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.7.1.3 Germany Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.8 France: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.8.1 France: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.1 France Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.2 France Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.8.1.3 France Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.9 United Kingdom: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.9.1 United Kingdom: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.1 United Kingdom Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.2 United Kingdom Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.9.1.3 United Kingdom Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.10 Italy: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.10.1 Italy: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.1 Italy Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.2 Italy Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.10.1.3 Italy Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.2.11 Spain: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.2.11.1 Spain: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.1 Spain Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.2 Spain Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.2.11.1.3 Spain Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.3 Asia Pacific: Bioactive Wound Management Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
    • 10.3.3 Asia Pacific: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
    • 10.3.4 Asia Pacific: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
    • 10.3.5 Asia Pacific: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.6 Asia Pacific: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.3.7 China: Bioactive Wound Management Market
      • 10.3.7.1 China: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.7.1.1 China: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.7.1.2 China: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.7.1.3 China: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.8 Japan: Bioactive Wound Management Market
      • 10.3.8.1 Japan: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.8.1.1 Japan: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.8.1.2 Japan: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.8.1.3 Japan: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.9 India: Bioactive Wound Management Market
      • 10.3.9.1 India: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.9.1.1 India: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.9.1.2 India: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.9.1.3 India: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.10 South Korea: Bioactive Wound Management Market
      • 10.3.10.1 South Korea: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.10.1.1 South Korea: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.10.1.2 South Korea: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.10.1.3 South Korea: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
    • 10.3.11 Australia: Bioactive Wound Management Market
      • 10.3.11.1 Australia: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Millions)
        • 10.3.11.1.1 Australia: Bioactive Wound Management Market, by Product, 2018-2031 (USD Millions)
        • 10.3.11.1.2 Australia: Bioactive Wound Management Market, by Application, 2018-2031 (USD Millions)
        • 10.3.11.1.3 Australia: Bioactive Wound Management Market, by End User, 2018-2031 (USD Millions)
  • 10.4 Middle East and Africa: Bioactive Wound Management Market
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Bioactive Wound Management Market- Revenue and Forecast to 2031 (USD Million)
    • 10.4.3 Middle East and Africa Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.4.4 Middle East and Africa Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 10.4.5 Middle East and Africa Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.6 Middle East and Africa: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.4.7 Saudi Arabia: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.7.1 Saudi Arabia: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.1 Saudi Arabia Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.2 Saudi Arabia Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.4.7.1.3 Saudi Arabia Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.8 UAE: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.8.1 UAE: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.1 UAE Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.2 UAE Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.4.8.1.3 UAE Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.4.9 South Africa: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.1 South Africa: Bioactive Wound Management Marketand Revenue and Forecast to 2031 (USD Million)
        • 10.4.9.1.1 South Africa Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.4.9.1.2 South Africa Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
      • 10.4.9.2 South Africa Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
  • 10.6 South and Central America: Bioactive Wound Management Market
    • 10.6.1 Overview
    • 10.6.2 South and Central America: Bioactive Wound Management Market - Revenue and Forecast to 2031 (USD Million)
    • 10.6.3 South and Central America Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
    • 10.6.4 South and Central America Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
    • 10.6.5 South and Central America Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.6.6 South and Central America: Bioactive Wound Management Market, by Country, 2024 and 2031 (%)
    • 10.6.7 Brazil: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.6.7.1 Brazil: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.1 Brazil Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.2 Brazil Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.6.7.1.3 Brazil Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)
    • 10.6.8 Argentina: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
      • 10.6.8.1 Argentina: Bioactive Wound Management Market and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.1 Argentina Bioactive Wound Management Market, by Product and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.2 Argentina Bioactive Wound Management Market, by Application and Revenue and Forecast to 2031 (USD Million)
        • 10.6.8.1.3 Argentina Bioactive Wound Management Market, by End User and Revenue and Forecast to 2031 (USD Million)

11. Impact of COVID-19 Pandemic On Global Bioactive Wound Management Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

12. Bioactive Wound Management MarketandIndustry Landscape

  • 12.1 Overview
  • 12.1 Growth Strategies Done by the Companies in the Market, (%)
  • 12.2 Organic Developments
    • 12.2.1 Overview
  • 12.3 Inorganic Developments
    • 12.3.1 Overview

13. COMPANY PROFILES

  • 13.1 Covalon Technologies Ltd.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 ConvaTec Group Plc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Coloplast Group
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Tissue Regenix Group
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Hartman Group
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Smith and Nephew
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Integra Life Sciences Corporation
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Organogenesis Inc.
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 MiMedx
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ETS Wound Care, LLC
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Word Index